Going To The Big Show: Former Pink-Sheet Neurotrope's First Day On The Nasdaq

By: via Benzinga
A biotech company making a jump from the OTC market to the Nasdaq is certainly not as difficult as finding a cure for Alzheimer’s ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.